Citation Impact

Citing Papers

Parenteral Anticoagulants
2012 Standout
Mechanisms of Thrombus Formation
2008 Standout
Sox9 Modulates Proliferation and Expression of Osteogenic Markers of Adipose-Derived Stem Cells (ASC)
2013 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Human Fibrinogen
1988
An elastase-dependent pathway of plasminogen activation
1989
Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma Fibrinolysis
2001
NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata
1994 StandoutNobel
Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons
1994 Standout
The molecular basis of blood coagulation
1988 Standout
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
1997 StandoutNature
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Extracellular matrix structure
2015 Standout
Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor
1990
The coagulation cascade: initiation, maintenance, and regulation
1991 Standout
Haemostatic abnormalities in patients with liver disease
2002
Endocrine Regulation of Energy Metabolism by the Skeleton
2007 Standout
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Autoactivation of human recombinant coagulation factor VII
1989
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells
1988
Molecular and Cellular Biology of Blood Coagulation
1992
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Dosing with recombinant factor viia based on current evidence
2004
Tissue‐type plasminogen activator‐mediated plasminogen activation and contact activation, implications in and beyond haemostasis
2011
How to measure and predict the molar absorption coefficient of a protein
1995 Standout
The course and prerequisites of Lys-plasminogen formation during fibrinolysis
1988
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Recurrent miscarriage
2006 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Regulation of coagulation by a multivalent Kunitz-type inhibitor
1990
The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage
1988
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Preeclampsia: An excessive maternal inflammatory response to pregnancy
1999 Standout
Identification of Hypoxically Inducible mRNAs in HeLa Cells Using Differential‐Display PCR
1996 StandoutNobel
Molecular cloning and expression of human hepatocyte growth factor
1989 StandoutNature
Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism
1991 StandoutNobel
Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation.
1987
Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells
1981
Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells
1989
Affinity purification of human tissue factor: interaction of factor VII and tissue factor in detergent micelles.
1986
Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments
1982
Deficiency of protein C in congenital thrombotic disease.
1981 Standout
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
1986 Standout
Nucleotide sequence of a cDNA for a member of the human 90-kDa heat-shock protein family
1987 StandoutNobel
Activation of human factor VII by activated factors IX and X
1982
On the Regulation and Control of Fibrinolysis
1980
Isolation and characterization of urokinase from human plasma.
1982
Serpin Structure, Mechanism, and Function
2002 Standout
Purification and characterization of human vascular plasminogen activator
1980
Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position −4
1986
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82)
1989
Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA.
1987
Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.
1988
Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
1981
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Heparin-copper biaffinity chromatography of fibroblast growth factors.
1988
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
1976 Standout
Molar absorptivity and A1cm1% values for proteins at selected wavelengths of the ultraviolet and visible regions. VIII
1973
Purification and properties of human coagulation factor VII.
1980
Characterization of a cDNA coding for human factor VII.
1986
Purification and partial characterization of plasminogen activator from human uterine tissue
1979
The mechanism of in vitro clot lysis induced by vascular plasminogen activator
1984
Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa.
1985
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
1982
A factor X-activating cysteine protease from malignant tissue.
1981
A direct, plasmin-independent assay for plasminogen activator
1984
Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor.
1980
Purification and characterization of bovine tissue factor.
1981
F4/80, a monoclonal antibody directed specifically against the mouse macrophage
1981 Standout
Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH
1982
Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts
1977
An association between the factor VII coagulant activity and thrombin activity induced by surface/cold exposure of normal human plasma
1986
Glycobiology:  Toward Understanding the Function of Sugars
1996 Standout
Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate
1980
Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.
1982
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Tissue Factor: An Enzyme Cofactor and a True Receptor
2001
Macrophage component gp160, a major trypsin-sensitive surface glycoprotein.
1980
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
1986 Standout
Vitamin K, Prothrombin, and γ‐Carboxyglutamic Acid
1978
Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
1981
Actin accelerates plasmin generation by tissue plasminogen activator.
1991
Activation of Protein C In Vivo
1982
Cooperative interaction between factor VII and cell surface-expressed tissue factor.
1987
Molar absorptivity and A1cm1% values for proteins at selected wavelengths of the ultraviolet and visible regions. XII
1977
Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.
1983
Whole blood clot lysis: In vitro modulation by activated protein C
1985
Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine
1986
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
1988 Standout
A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase.
1976
A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization.
1976
Trinitrobenzoylated poly(d-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator
1986
Molar absorptivity and A1 cm1% values for proteins at selected wavelengths of the ultraviolet and visible regions. XIV
1977
Secretory products of macrophages.
1987 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Generation of fibrinolytic activity by infusion of activated protein C into dogs.
1981
Prohormone processing in Xenopus oocytes: characterization of cleavage signals and cleavage enzymes.
1991 StandoutNobel
Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system
1984
Tumors: Wounds That Do Not Heal
1986 Standout
cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family.
1989 StandoutNobel
The Structural Biology of Expression and Function of Tissue Factor
1991
An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage
1986
The Tissue Factor Pathway: How It Has Become a “Prima Ballerina”
1995
Binding of human factor VII and VIIa to monocytes.
1982
The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII
1990
Tissue factor accelerates the activation of coagulation factor VII: The role of a bifunctional coagulation cofactor
1985
Relationship between tissue plasminogen activator and the activators in blood and vascular wall
1980
Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease.
1985
The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
1982
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
1987 Standout
Content and characterization of plasminogen activators in human lung tumors and normal lung tissue.
1980
Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
1984 Standout
Relationship Between Release of Plasminogen Activator and Estrogen by Blastocysts and Secretion of Plasmin Inhibitor by Uterine Endometrium in the Pregnant Pig
1983
Haemostasis in Normal Pregnancy
1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activator.
1984
Comparative Study with Two Polar Types of Murine Leprosy: An Involvement of Plasminogen Activator and Its Possible Regulating Factor in the Granulomatous Tissue Reaction
1983
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
1990 StandoutNobel
Mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa(activated plasma thromboplastin antecedent)
1974
Factor XI Activation in a Revised Model of Blood Coagulation
1991 Science
A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogen
1983
Angiogenesis.
1992 Standout
Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.
1990
Assay of factor VII activity by two techniques: evidence for increased conversion of VII to αVIIain hyperlipidaemia, with possible implications for ischaemic heart disease
1985

Works of Robert Radcliffe being referenced

Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII
1975
The Purification and Properties of Activated Factor X
1972
[6] Bovine factor VII
1976
Comparisons of the Molecular Forms of Activated Bovine Factor X
1973
A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
1981
A critical role of lysine residues in the stimulation of tissue plasminogen activator by denatured proteins and fibrin clots
1983
Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: A possible additional role for plasminogen activator?
1981
Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa.
1976
Isolation of plasminogen activator from human plasma by chromatography on lysine-Sepharose
1978
The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen.
1982
Rankless by CCL
2026